SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : InterMune (nasdaq)ITMN -- Ignore unavailable to you. Want to Upgrade?

To: IRWIN JAMES FRANKEL who wrote (227)4/26/2002 1:26:07 PM
From: keokalani'nui  Respond to of 508
 
I am looking at a slide from a recent presentation (BoA?),
it shows unaudited P2 data indicating:

9 control, with approx 29% survival after 5 years
9 drug, with approx 70% survival after 5 years
p= 0.029

Small, TINY, population, and the curves do not diverge until shortly after year 2.

NO other variables mentioned. So, take it with/.

(note: very hard to read the scale with a ruler)

Wilder


HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News